Citigroup »

Heron Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $31k 18k 1.70
2023-09-30 $216 210 1.03
2023-03-31 $16k 10k 1.51
2022-12-31 $28k 11k 2.50
2022-09-30 $2.4M 557k 4.33
2021-12-31 $4.0M 441k 9.13
2021-03-31 $0 247k 0.00
2020-12-31 $0 21k 0.00
2020-09-30 $0 6.0k 0.00
2020-06-30 $0 61k 0.00
2020-03-31 $853k 73k 11.75
2019-12-31 $1.8M 75k 23.58
2019-09-30 $3.4M 178k 18.87
2019-06-30 $4.9M 265k 18.59
2019-03-31 $1.3M 52k 24.43
2018-12-31 $3.7M 142k 25.94
2018-09-30 $986k 31k 31.63
2018-06-30 $2.5M 65k 38.94
2018-03-31 $8.1M 294k 27.61
2017-12-31 $13M 711k 18.10
2017-09-30 $13M 788k 16.15
2017-06-30 $15M 1.1M 13.85
2017-03-31 $785k 52k 15.01
2016-12-31 $2.9M 223k 13.10
2016-09-30 $486k 28k 17.25
2016-06-30 $694k 38k 18.04
2015-12-31 $590k 22k 27.32
2015-09-30 $6.3M 260k 24.38
2015-06-30 $111k 3.5k 31.25
2014-09-30 $7.3k 846 8.65
2014-03-31 $999 69 14.49